SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹0.86 Cr | ₹0.55 Cr | ₹0.55 Cr | ₹0.55 Cr | ₹2.74 Cr |
What is the latest Contingent Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹0.86 Cr |
| Mar2024 | ₹0.55 Cr |
| Mar2023 | ₹0.55 Cr |
| Mar2022 | ₹0.55 Cr |
| Mar2017 | ₹2.74 Cr |
How is Contingent Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.86 Cr | 56.18 | |
| Mar2024 | ₹0.55 Cr | 0.00 | |
| Mar2023 | ₹0.55 Cr | 0.00 | |
| Mar2022 | ₹0.55 Cr | -79.96 | |
| Mar2017 | ₹2.74 Cr | - | |
Compare Contingent Liabilities of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,290.6 Cr | 2% | 25.4% | -19.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 2% |
25.4% |
-19.2% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses